Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Neuromedin U Does Not Act as a Decretin in Rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Mechanisms Preserving Insulin Action during High Dietary Fat Intake

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Gluco-metabolic effects of oral and intravenous alcohol administration in men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Gastric emptying is a critical regulator of postprandial glucose and delayed gastric emptying is an important mechanism of improved glycemic control achieved by short-acting glucagon-like peptide-1 (GLP-1) analogs in clinical practice. Here we report on a novel regulatory mechanism of gastric emptying in humans. We show that increasing interleukin (IL)-6 concentrations delays gastric emptying leading to reduced postprandial glycemia. IL-6 furthermore reduces insulin secretion in a GLP-1-dependent manner while effects on gastric emptying are GLP-1 independent. Inhibitory effects of IL-6 on gastric emptying were confirmed following exercise-induced increases in IL-6. Importantly, gastric- and insulin-reducing effects were maintained in individuals with type 2 diabetes. These data have clinical implications with respect to the use of IL-6 inhibition in autoimmune/inflammatory disease, and identify a novel target that could be exploited pharmacologically to delay gastric emptying and spare insulin, which may be beneficial for the beta cell in type 2 diabetes.

OriginalsprogEngelsk
TidsskriftCell Metabolism
Vol/bind27
Udgave nummer6
Sider (fra-til)1201-1211.e3
ISSN1550-4131
DOI
StatusUdgivet - 5 jun. 2018

ID: 56586575